Prevention of cardiovascular disease in uncomplicated, mild hypertension – need for prospective data from intervention trials

Author： Kjeldsen Sverre   Hedner Thomas   Himmelmann Anders  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.13, Iss.1, 2004-02, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Opinion and Evidence in Hypertension and Cardiovascular Disease Prevention

By Adis International Limited  

High Blood Pressure & Cardiovascular Prevention, Vol. 11, Iss. 2, 2004-01 ,pp. : 83-86

Adis International

Access to resources Recommend Favorite

Opinion and Evidence in Hypertension and Cardiovascular Disease Prevention

By Adis International Limited  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 1, 2005-01 ,pp. : 45-51

Adis International

Access to resources Recommend Favorite

Hyperuricemia, Cardiovascular Disease, and Hypertension

By  

Pulse, Vol. 3, Iss. 3-4, 2016-03 ,pp. : 242-252

Karger

Access to resources Recommend Favorite

Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

By Sawicki P.   Kaiser T.  

Diabetologia, Vol. 47, Iss. 6, 2004-06 ,pp. : 976-977

Springer Publishing Company

Access to resources Recommend Favorite

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

By Chiasson J.-L.   Josse R.   Gomis R.   Hanefeld M.   Karasik A.   Laakso M.  

Diabetologia, Vol. 47, Iss. 6, 2004-06 ,pp. : 969-975

Springer Publishing Company

Access to resources Recommend Favorite